- Published on
Diagnostic Tests – Colposcopy
1. What Is a Colposcopy?
A colposcopy is a gynecologic procedure that allows direct, magnified visualization of the cervix, vagina, and transformation zone using a specialized instrument called a colposcope—a lighted binocular microscope. The device is placed at the vaginal introitus (not inside the vagina like a speculum) and provides enhanced detail of cervical epithelial changes. Clinicians often apply acetic acid or Lugol’s iodine during the procedure to highlight abnormal areas, making precancerous lesions easier to identify and biopsy. The purpose of a colposcopy is to further evaluate abnormalities detected on cervical cancer screening tests, particularly when cytology suggests dysplasia.
2. What Must Be Visualized for an Adequate Study?
For a colposcopy to be considered adequate, the provider must be able to clearly visualize the transformation zone—the area where squamous epithelium of the ectocervix meets the columnar epithelium of the endocervix. This squamocolumnar junction is the region most susceptible to HPV-related dysplastic changes and is where cervical intraepithelial neoplasia (CIN) typically arises. If the transformation zone cannot be fully seen—either because it resides high in the endocervical canal, or the view is obstructed—the colposcopy is termed inadequate and may require an endocervical curettage or additional management.
3. When Is Colposcopy the Correct Next Step?
Colposcopy is most appropriate when a patient has an abnormal Pap smear requiring further evaluation. It becomes the next diagnostic step when cytology suggests premalignant or high-risk cervical disease. Specifically, colposcopy is indicated when any of the following appear on Pap testing:
In these scenarios, colposcopy allows for direct inspection and targeted biopsy of abnormal cervical areas, which is essential for diagnosing and grading CIN and determining appropriate management.
1. What Is a Colposcopy?
A colposcopy is a gynecologic procedure that allows direct, magnified visualization of the cervix, vagina, and transformation zone using a specialized instrument called a colposcope—a lighted binocular microscope. The device is placed at the vaginal introitus (not inside the vagina like a speculum) and provides enhanced detail of cervical epithelial changes. Clinicians often apply acetic acid or Lugol’s iodine during the procedure to highlight abnormal areas, making precancerous lesions easier to identify and biopsy. The purpose of a colposcopy is to further evaluate abnormalities detected on cervical cancer screening tests, particularly when cytology suggests dysplasia.
2. What Must Be Visualized for an Adequate Study?
For a colposcopy to be considered adequate, the provider must be able to clearly visualize the transformation zone—the area where squamous epithelium of the ectocervix meets the columnar epithelium of the endocervix. This squamocolumnar junction is the region most susceptible to HPV-related dysplastic changes and is where cervical intraepithelial neoplasia (CIN) typically arises. If the transformation zone cannot be fully seen—either because it resides high in the endocervical canal, or the view is obstructed—the colposcopy is termed inadequate and may require an endocervical curettage or additional management.
3. When Is Colposcopy the Correct Next Step?
Colposcopy is most appropriate when a patient has an abnormal Pap smear requiring further evaluation. It becomes the next diagnostic step when cytology suggests premalignant or high-risk cervical disease. Specifically, colposcopy is indicated when any of the following appear on Pap testing:
- ASC-H (Atypical Squamous Cells—cannot exclude HSIL)
- LSIL (Low-Grade Squamous Intraepithelial Lesion)
- HSIL (High-Grade Squamous Intraepithelial Lesion)
- ASC-US (Atypical Squamous Cells of Undetermined Significance) when the HPV DNA test is positive
In these scenarios, colposcopy allows for direct inspection and targeted biopsy of abnormal cervical areas, which is essential for diagnosing and grading CIN and determining appropriate management.
- Published on
Diagnostic Tests – Ventricular Fibrillation (Vfib)
What Is This?
The EKG demonstrates ventricular fibrillation (Vfib), a lethal cardiac arrhythmia and one of the primary causes of sudden cardiac death. Ventricular fibrillation occurs when the ventricles quiver in a chaotic, uncoordinated manner rather than contracting effectively. Because there is no organized ventricular activity, the heart cannot generate a pulse or maintain any blood pressure. Recognizing Vfib on an EKG is critical because it requires immediate defibrillation to restore organized cardiac rhythm and perfusion.
What Is the Characteristic EKG Feature That Gives the Diagnosis?
The characteristic feature of Vfib on an EKG is the complete absence of organized electrical activity. The tracing shows no P-waves, no QRS complexes, and no discernible rhythm. Instead, the strip displays a chaotic, irregular pattern with either low-amplitude fine fibrillation waves or high-amplitude coarse fibrillation waves. Despite the disorganized activity, Vfib is not the same as asystole—the line is not flat, and electrical activity is still present, but it is functionally useless. If you can identify any organized complexes or repeating rhythm, the diagnosis is not Vfib.
What Case Will Go Along With This EKG?
A typical case involving Vfib describes a patient in full cardiac arrest. These patients have no pulse, no blood pressure, and no respirations, and they collapse suddenly. They may have a prior history of coronary artery disease, myocardial infarction, cardiomyopathy, severe electrolyte imbalance (such as hypokalemia), or acute ischemia, but Vfib can also occur without warning. Clinically, Vfib cannot be distinguished from other forms of pulseless arrest—such as asystole, pulseless electrical activity (PEA), or pulseless ventricular tachycardia—without an EKG. Therefore, rapid rhythm identification is essential so that immediate defibrillation can be performed, which is the only lifesaving treatment for Vfib.
What Is This?
The EKG demonstrates ventricular fibrillation (Vfib), a lethal cardiac arrhythmia and one of the primary causes of sudden cardiac death. Ventricular fibrillation occurs when the ventricles quiver in a chaotic, uncoordinated manner rather than contracting effectively. Because there is no organized ventricular activity, the heart cannot generate a pulse or maintain any blood pressure. Recognizing Vfib on an EKG is critical because it requires immediate defibrillation to restore organized cardiac rhythm and perfusion.
What Is the Characteristic EKG Feature That Gives the Diagnosis?
The characteristic feature of Vfib on an EKG is the complete absence of organized electrical activity. The tracing shows no P-waves, no QRS complexes, and no discernible rhythm. Instead, the strip displays a chaotic, irregular pattern with either low-amplitude fine fibrillation waves or high-amplitude coarse fibrillation waves. Despite the disorganized activity, Vfib is not the same as asystole—the line is not flat, and electrical activity is still present, but it is functionally useless. If you can identify any organized complexes or repeating rhythm, the diagnosis is not Vfib.
What Case Will Go Along With This EKG?
A typical case involving Vfib describes a patient in full cardiac arrest. These patients have no pulse, no blood pressure, and no respirations, and they collapse suddenly. They may have a prior history of coronary artery disease, myocardial infarction, cardiomyopathy, severe electrolyte imbalance (such as hypokalemia), or acute ischemia, but Vfib can also occur without warning. Clinically, Vfib cannot be distinguished from other forms of pulseless arrest—such as asystole, pulseless electrical activity (PEA), or pulseless ventricular tachycardia—without an EKG. Therefore, rapid rhythm identification is essential so that immediate defibrillation can be performed, which is the only lifesaving treatment for Vfib.
- Published on
Diagnostic Tests – Ventricular Tachycardia (VT)
What Is the Diagnosis?
The EKG demonstrates ventricular tachycardia (VT), a dangerous arrhythmia characterized by a wide-complex tachycardia, with QRS complexes greater than 120 milliseconds. VT originates from the ventricles rather than the atria, which results in broad, abnormal QRS complexes that appear uniform or slightly varied depending on the underlying mechanism. By board exam convention, any regular wide-complex tachycardia should be assumed to be VT unless proven otherwise, making this an essential recognition pattern in cardiology.
What Case Will Go Along With This EKG?
Ventricular tachycardia can present with a wide range of symptoms, from mild palpitations to life-threatening instability. A typical case might involve a patient who develops syncope, lightheadedness, shortness of breath, or symptoms of congestive heart failure. In severe situations, VT may cause sudden cardiac death, emphasizing the need for rapid diagnosis and treatment. VT commonly occurs in patients with underlying structural heart disease, such as prior myocardial infarction, cardiomyopathy, severe electrolyte disturbances, or antiarrhythmic drug toxicity. Because symptoms alone cannot reliably identify VT, the EKG is essential for diagnosis.
How Do You Treat It?
Treatment of ventricular tachycardia depends entirely on patient stability. When the patient is unstable—with hypotension, chest pain, altered mental status, or signs of shock—the correct and immediate treatment is synchronized electrical cardioversion, which is lifesaving. For stable patients who are maintaining blood pressure and mentation, pharmacologic therapy is appropriate. Intravenous amiodarone is typically first-line, while lidocaine (especially in post–MI patients) and procainamide are effective alternatives. Regardless of the initial approach, VT is a serious arrhythmia that demands prompt intervention and frequently leads to further diagnostic evaluation, such as electrophysiology studies, to determine its etiology.
What Is the Diagnosis?
The EKG demonstrates ventricular tachycardia (VT), a dangerous arrhythmia characterized by a wide-complex tachycardia, with QRS complexes greater than 120 milliseconds. VT originates from the ventricles rather than the atria, which results in broad, abnormal QRS complexes that appear uniform or slightly varied depending on the underlying mechanism. By board exam convention, any regular wide-complex tachycardia should be assumed to be VT unless proven otherwise, making this an essential recognition pattern in cardiology.
What Case Will Go Along With This EKG?
Ventricular tachycardia can present with a wide range of symptoms, from mild palpitations to life-threatening instability. A typical case might involve a patient who develops syncope, lightheadedness, shortness of breath, or symptoms of congestive heart failure. In severe situations, VT may cause sudden cardiac death, emphasizing the need for rapid diagnosis and treatment. VT commonly occurs in patients with underlying structural heart disease, such as prior myocardial infarction, cardiomyopathy, severe electrolyte disturbances, or antiarrhythmic drug toxicity. Because symptoms alone cannot reliably identify VT, the EKG is essential for diagnosis.
How Do You Treat It?
Treatment of ventricular tachycardia depends entirely on patient stability. When the patient is unstable—with hypotension, chest pain, altered mental status, or signs of shock—the correct and immediate treatment is synchronized electrical cardioversion, which is lifesaving. For stable patients who are maintaining blood pressure and mentation, pharmacologic therapy is appropriate. Intravenous amiodarone is typically first-line, while lidocaine (especially in post–MI patients) and procainamide are effective alternatives. Regardless of the initial approach, VT is a serious arrhythmia that demands prompt intervention and frequently leads to further diagnostic evaluation, such as electrophysiology studies, to determine its etiology.
- Published on
Diagnostic Tests – Multifocal Atrial Tachycardia (MAT)
Overview of MAT
Multifocal atrial tachycardia (MAT) is an arrhythmia in which the atria initiate electrical impulses from multiple different pacemaker sites rather than a single dominant focus. This leads to a rapid heart rhythm—typically over 100 beats per minute—with identifiable but variable P waves, each originating from a different atrial location. Unlike atrial fibrillation, where the baseline is chaotic and true P waves are absent, MAT shows distinct P-wave activity even though the atrial rhythm is disorganized. The impulses still travel through the AV node, producing normal, narrow QRS complexes that appear at irregular intervals.
EKG Characteristics
One of the key diagnostic features of MAT is its irregular timing between beats. Both P–P intervals and R–R intervals vary continuously, giving the rhythm an “irregularly irregular” appearance. What sets MAT apart from similar arrhythmias is the presence of at least three different P-wave morphologies, reflecting shifting atrial pacemaker sites. Because each focus conducts through the AV node differently, the PR intervals also change from beat to beat. When the heart rate is below 100 beats per minute but the same shifting pacemaker pattern is present, the rhythm is called a wandering atrial pacemaker, which represents a slower version of the same phenomenon.
Most Common Causes
The condition is most strongly linked to chronic lung disease, particularly during exacerbations of chronic obstructive pulmonary disease (COPD). Chronic hypoxia, hypercapnia, and increased sympathetic tone disrupt atrial electrical stability, causing multiple atrial sites to fire chaotically. Right atrial enlargement or stretch from long-standing pulmonary hypertension further destabilizes atrial conduction. Electrolyte abnormalities—especially low potassium or magnesium—often worsen atrial irritability. Medications such as theophylline, historically used for COPD, can also provoke MAT due to their stimulatory effects on the heart. Although conditions like pulmonary embolism and severe congestive heart failure can also produce similar arrhythmias, COPD remains the most common underlying cause.
- Published on
Diagnostic Tests – Asystole
What Is This?
The EKG demonstrates asystole, a rhythm that indicates the near-complete absence of electrical activity in the heart. In asystole, the myocardium is electrically silent and unable to generate a coordinated contraction, resulting in the absence of a pulse or blood pressure. Although commonly referred to as “flatline,” true asystole does not usually produce a perfectly straight line—small baseline undulations may still appear—but there are no identifiable P-waves, QRS complexes, or organized rhythm. Asystole represents one of the most severe and final forms of cardiac arrest.
What Is the Characteristic EKG Feature That Gives the Diagnosis?
The defining characteristic of asystole on EKG is the lack of any meaningful electrical activity whatsoever. Unlike ventricular fibrillation—which shows chaotic, irregular electrical waves—or ventricular tachycardia—which shows wide, organized complexes—asystole shows no complexes at all. The tracing consists of minimal, non-specific baseline oscillation. If you can identify any organized rhythm, such as QRS complexes or discernible P-waves, the diagnosis is not asystole. The flat, near-silent pattern is what establishes the diagnosis.
What Case Will Go Along With This EKG?
A patient with asystole will be in full cardiac arrest with no pulse, no blood pressure, and no respirations. The onset is sudden, and the patient collapses immediately. Asystole is typically the result of prolonged cardiac arrest, massive myocardial infarction, severe hypoxia, advanced metabolic derangements, or final-stage deterioration following ventricular fibrillation. Clinically, asystole cannot be distinguished from other causes of pulselessness—such as ventricular fibrillation, pulseless electrical activity (PEA), cardiac tamponade, or tension pneumothorax—without obtaining an EKG. Therefore, rhythm identification is essential to determine the correct management pathway, though asystole itself is not shockable, unlike Vfib.
What Is This?
The EKG demonstrates asystole, a rhythm that indicates the near-complete absence of electrical activity in the heart. In asystole, the myocardium is electrically silent and unable to generate a coordinated contraction, resulting in the absence of a pulse or blood pressure. Although commonly referred to as “flatline,” true asystole does not usually produce a perfectly straight line—small baseline undulations may still appear—but there are no identifiable P-waves, QRS complexes, or organized rhythm. Asystole represents one of the most severe and final forms of cardiac arrest.
What Is the Characteristic EKG Feature That Gives the Diagnosis?
The defining characteristic of asystole on EKG is the lack of any meaningful electrical activity whatsoever. Unlike ventricular fibrillation—which shows chaotic, irregular electrical waves—or ventricular tachycardia—which shows wide, organized complexes—asystole shows no complexes at all. The tracing consists of minimal, non-specific baseline oscillation. If you can identify any organized rhythm, such as QRS complexes or discernible P-waves, the diagnosis is not asystole. The flat, near-silent pattern is what establishes the diagnosis.
What Case Will Go Along With This EKG?
A patient with asystole will be in full cardiac arrest with no pulse, no blood pressure, and no respirations. The onset is sudden, and the patient collapses immediately. Asystole is typically the result of prolonged cardiac arrest, massive myocardial infarction, severe hypoxia, advanced metabolic derangements, or final-stage deterioration following ventricular fibrillation. Clinically, asystole cannot be distinguished from other causes of pulselessness—such as ventricular fibrillation, pulseless electrical activity (PEA), cardiac tamponade, or tension pneumothorax—without obtaining an EKG. Therefore, rhythm identification is essential to determine the correct management pathway, though asystole itself is not shockable, unlike Vfib.
- Published on
Diagnostic Tests – Ergonovine Test
What Is the Ergonovine Test?
The ergonovine test is a specialized diagnostic procedure used in cardiology to intentionally provoke coronary vasospasm—a sudden, temporary narrowing of the coronary arteries. During this test, a medication called ergonovine is administered, usually intravenously, under controlled conditions. Ergonovine causes smooth muscle contraction, and in individuals with underlying Prinzmetal’s (variant) angina, this can trigger a brief episode of chest pain along with transient ST-segment elevation on ECG.
This controlled provocation helps clinicians determine whether chest pain is due to reversible spasm rather than fixed atherosclerotic obstruction.
When Is Ergonovine Testing the Correct Diagnostic Choice?
Ergonovine testing becomes the most useful—and often the most accurate—diagnostic test in situations where coronary artery spasm is strongly suspected. This typically involves patients who:
- Are younger than 45 years old,
- Report atypical anginal symptoms,
- Experience chest discomfort not reliably triggered by exertion, and
- Have normal or “clean” coronary arteries on cardiac catheterization.
These patients often present with episodes of chest pain occurring at rest, sometimes cyclically or at night. Because their coronary arteries do not show significant plaque buildup, vasospasm becomes the likely mechanism, and the ergonovine test can help confirm it by reproducing symptoms and ECG changes.
Treatment for Prinzmetal’s (Variant) Angina
Once coronary vasospasm is confirmed, treatment focuses on preventing future episodes by relaxing the coronary arteries and reducing the likelihood of spasm. The primary therapies include:
- Calcium channel blockers (e.g., diltiazem, amlodipine, verapamil), which reduce smooth muscle contraction and stabilize the coronary vessels.
- Nitrates (short-acting or long-acting), which provide vasodilation and rapid symptom relief when episodes occur.
In addition, avoiding triggers—such as smoking, cocaine use, or cold exposure—can help reduce the frequency of vasospastic events.
- Published on
Click here to start customizing
- Published on
Diagnostic Tests – Stress Echocardiogram
What Is a Stress Echocardiogram?
A stress echocardiogram is a noninvasive cardiac diagnostic test used to evaluate suspected coronary artery disease (CAD) and to assess the severity of ischemia. It combines the physiologic stress of exercise (or pharmacologic stimulation) with cardiac imaging to reveal how the heart functions when its oxygen demand increases. The goal is to uncover abnormalities in cardiac muscle contraction that only appear when the heart is stressed, helping clinicians determine whether blood flow to the myocardium is compromised.
How Is the Test Performed?
This test uses a combination of 2-dimensional echocardiography and Doppler imaging to evaluate cardiac structure, motion, and blood flow. First, baseline images of the heart are taken at rest. The patient is then stressed either by exercise—typically on a treadmill or bicycle—or, if they are unable to exercise, by administration of dobutamine, which increases heart rate and myocardial oxygen demand in a controlled manner.
After the heart reaches the target stress level, echocardiographic images are taken again. These “before and after” images allow the physician to determine whether the myocardium develops signs of ischemia, such as reduced contraction in specific segments.
What Constitutes a Positive Stress Echo?
A stress echocardiogram is considered positive when stress induces signs that suggest myocardial ischemia. Key findings include:
These findings reveal that certain parts of the heart are not receiving adequate blood supply during stress, consistent with underlying coronary artery disease.
When Should You Choose a Stress Echocardiogram?
A stress echo is the appropriate diagnostic answer when:
In such scenarios, standard exercise EKG testing cannot be trusted, and stress echocardiography becomes the preferred method because it provides visual evidence of ischemia even when the EKG cannot
What Is a Stress Echocardiogram?
A stress echocardiogram is a noninvasive cardiac diagnostic test used to evaluate suspected coronary artery disease (CAD) and to assess the severity of ischemia. It combines the physiologic stress of exercise (or pharmacologic stimulation) with cardiac imaging to reveal how the heart functions when its oxygen demand increases. The goal is to uncover abnormalities in cardiac muscle contraction that only appear when the heart is stressed, helping clinicians determine whether blood flow to the myocardium is compromised.
How Is the Test Performed?
This test uses a combination of 2-dimensional echocardiography and Doppler imaging to evaluate cardiac structure, motion, and blood flow. First, baseline images of the heart are taken at rest. The patient is then stressed either by exercise—typically on a treadmill or bicycle—or, if they are unable to exercise, by administration of dobutamine, which increases heart rate and myocardial oxygen demand in a controlled manner.
After the heart reaches the target stress level, echocardiographic images are taken again. These “before and after” images allow the physician to determine whether the myocardium develops signs of ischemia, such as reduced contraction in specific segments.
What Constitutes a Positive Stress Echo?
A stress echocardiogram is considered positive when stress induces signs that suggest myocardial ischemia. Key findings include:
- New regional wall motion abnormalities (the hallmark sign): ischemic areas show reduced or absent systolic contraction.
- A drop in left ventricular ejection fraction, indicating impaired global function under stress.
- An increase in end-systolic volume, reflecting the heart’s inability to effectively contract when demand increases.
These findings reveal that certain parts of the heart are not receiving adequate blood supply during stress, consistent with underlying coronary artery disease.
When Should You Choose a Stress Echocardiogram?
A stress echo is the appropriate diagnostic answer when:
- The clinical case is uncertain or equivocal for ischemic heart disease, and
- The resting EKG is too abnormal to interpret for ischemic changes during exercise (e.g., baseline ST-segment abnormalities, left bundle branch block, LVH with strain).
In such scenarios, standard exercise EKG testing cannot be trusted, and stress echocardiography becomes the preferred method because it provides visual evidence of ischemia even when the EKG cannot
- Published on
Diagnostic Tests – Stress (Exercise Tolerance) Testing
What Is Stress (Exercise Tolerance) Testing?
Stress testing, also known as exercise tolerance testing, is a noninvasive method used to detect myocardial ischemia without immediately resorting to coronary angiography. It is performed in patients whose chest pain does not provide a definite diagnosis of ischemic heart disease. By increasing the heart’s workload, the test helps determine whether the coronary arteries can supply enough blood to meet the myocardial oxygen demand. If blood flow is inadequate, electrical or symptomatic signs of ischemia will appear.
How Is the Test Performed?
During the test, the patient exercises—usually on a treadmill or stationary bicycle—until they reach greater than 80% of their maximum predicted heart rate, calculated as 220 minus age. Throughout the exercise, clinicians closely monitor the EKG for changes suggestive of ischemia, most notably ST-segment depression. In addition to EKG changes, development of hypotension, light-headedness, shortness of breath, or typical chest pain during the test is also considered evidence of ischemia. The test continues until symptoms appear, the target heart rate is achieved, or the patient cannot continue safely.
When Should Stress Testing Be Used?
Stress testing is the correct choice in several clinical scenarios where ischemia is suspected but not definitively established:
- When the patient’s chest pain is atypical and the clinical story is equivocal for ischemic heart disease.
- After a myocardial infarction, to determine whether there is a need for coronary angiography or further intervention.
- In patients already taking anti-ischemic medications, to assess whether the dosages are sufficient to prevent ischemia during exertion.
In cases like these, stress testing provides valuable diagnostic and prognostic information without immediately requiring invasive procedures.
What Is the Most Accurate Test After a Positive Stress Test?
If a stress test is abnormal, the next step—the most accurate confirmatory test—is coronary angiography. Angiography provides direct visualization of the coronary arteries, allowing identification of the exact location and severity of any obstructive lesions. It is the gold standard test when a stress test suggests ischemia and further evaluation is required.
- Published on
Diagnostic Tests – Persantine Thallium
What Is Persantine Thallium Testing?
Persantine thallium testing is a type of pharmacologic stress test used to evaluate myocardial perfusion in patients who cannot perform adequate physical exercise. Instead of using a treadmill or bicycle to increase the heart’s oxygen demand, this test uses medication to mimic the physiologic effects of exercise. It is noninvasive and helps determine whether areas of the heart receive sufficient blood flow under conditions that simulate stress.
How Is the Test Performed?
The test involves two major components: Persantine (dipyridamole) and thallium imaging.
Persantine is a phosphodiesterase inhibitor that causes coronary artery vasodilation, increasing blood flow to healthy myocardium. Diseased or stenotic coronary arteries, however, do not dilate as effectively, creating a “steal phenomenon” in which more blood flows to normal areas and less to ischemic areas.
After Persantine is administered, thallium, a radioactive tracer, is injected. Normal cardiac muscle takes up thallium readily, whereas ischemic or infarcted areas absorb significantly less. Imaging with a gamma camera then reveals patterns of perfusion, highlighting areas of reduced blood flow.
When Should You Choose Persantine Thallium Testing?
Persantine thallium is the correct diagnostic choice when a patient cannot exercise adequately for a standard treadmill stress test—but still requires evaluation of possible ischemic heart disease. This includes individuals with orthopedic limitations, neurologic conditions, deconditioning, or severe physical frailty.
It is also useful in preoperative cardiac risk assessment for patients with chest pain, when there is uncertainty about whether the pain represents ischemia.
When Is Persantine Thallium the Wrong Answer?
This test should NOT be selected in patients with asthma, COPD, or emphysema, because Persantine can provoke bronchospasm and worsen respiratory symptoms.
Additionally, any form of stress testing—including pharmacologic testing—is contraindicated in cases of acute myocardial infarction or unstable angina, where stressing the heart is unsafe and inappropriate.
What Is the Alternative Choice?
If Persantine cannot be used—especially due to respiratory disease—the preferred alternative is a dobutamine stress echocardiogram. Dobutamine increases myocardial oxygen demand by raising heart rate and contractility, functioning as a safe pharmacologic stress agent for patients who cannot tolerate Persantine.
What Is the Most Accurate Diagnostic Test?
Regardless of the stress modality used, the single most accurate test of myocardial perfusion and coronary anatomy is coronary angiography. It provides direct visualization of the coronary vessels, allowing clinicians to identify and quantify stenoses with precision
